Top Banner
John Dyson Head of Global Capital Projects - GlaxoSmithKline
43

John Dyson Head of Global Capital Projects - GlaxoSmithKline

Nov 11, 2021

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: John Dyson Head of Global Capital Projects - GlaxoSmithKline

John Dyson – Head of Global Capital Projects - GlaxoSmithKline

Page 2: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Born and bred in West Yorkshire

Graduated from University of Newcastle upon Tyne

Biochemistry & Nutrition

Graduate Scheme – Eden Vale

Moved to SmithKline Beecham in 1992 as Line Production

Manager – Horlicks First Project 1994

Page 3: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Father worked in Construction –

Modern Art Glass and Briggs Amasco

Spent holidays labouring on construction sites.

Page 4: John Dyson Head of Global Capital Projects - GlaxoSmithKline

• We are dedicated to improving the quality of human life by enabling people to do more, feel better and live longer.

Treatments for infections, depression, skin conditions, asthma, heart and circulatory disease and cancer.

More than 30 vaccines to prevent potentially life-threatening such as hepatitis A, hepatitis B, diphtheria, tetanus

Dental health products, over-the-counter medicines and nutritional drinks to millions of people

Page 5: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Total sales in emerging

markets now account for 26%

of our business

and grew 10% during 2012.

GlaxoSmithKline, Britain's biggest

drug-maker, has confirmed plans to

invest more than £500m in

manufacturing in Britain, creating up

to 1,000 new jobs as a result of tax

incentives introduced in the Budget.

Page 6: John Dyson Head of Global Capital Projects - GlaxoSmithKline

• Andrew Witty, CEO of GlaxoSmithKline said, “The patent box is exactly the sort of active, long-term and creative support that we need from the Government to ensure that the UK remains an attractive place for highly skilled sectors such as pharmaceuticals. For GSK, assuming the new regime will apply to patents currently under development it will have the immediate impact of making the UK a priority area for future investments, particularly in manufacturing.”

Page 7: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 8: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Construction/Design Benchmark – UK Metrics

UK Industry Performance Report , Constructing Excellence (2012), http://mimesolutions.com/PDFs/WEB%20Trish%20Melton%20Lean%20Manufacturing%20July%202005.pdf

Page 9: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Construction/Design Benchmark – US Productivity Metrics

An Introduction to Lean Construction, R. Blakey (no date) http://www.touchbriefings.com/pdf/3202/blakey.pdf

Page 10: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Delivering the supply-chains

of the future

TODAY!

Page 11: John Dyson Head of Global Capital Projects - GlaxoSmithKline

14-28 day delivery 1980 1 day delivery 2013

Analogue Brick 1980 4G smart phone 2013

Page 12: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Technology

Modular design

Off site construction

More collaborative approaches

Construction Know-how

Construction Logistics

Pharma design expertise

Page 13: John Dyson Head of Global Capital Projects - GlaxoSmithKline

A virtual place where people

work together on supply-chain solutions.

Page 14: John Dyson Head of Global Capital Projects - GlaxoSmithKline

CONCEPT

Page 15: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 16: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 17: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 18: John Dyson Head of Global Capital Projects - GlaxoSmithKline

BUSINESS DRIVEN & LEAN

Page 19: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Projects driven by Cost of Goods

Page 20: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Using process focused modular design to lean the construction.

And the whole site master-plans…

Page 21: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Identifying the right construction methodology to meet the business drivers.

Page 22: John Dyson Head of Global Capital Projects - GlaxoSmithKline

CHIP & MODELLING

Page 23: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Each supply chain is made of links: - critical steps or stages - CHIPs

Page 24: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Modelling facilities and supply chains to find the Right Project

Page 25: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 26: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 27: John Dyson Head of Global Capital Projects - GlaxoSmithKline

A supply-chain approach to projects.

Page 28: John Dyson Head of Global Capital Projects - GlaxoSmithKline

The Model looks at people .

Page 29: John Dyson Head of Global Capital Projects - GlaxoSmithKline

The model allows different phasing to be different products, different demand profiles to

be explored.

Near Real Time

Page 30: John Dyson Head of Global Capital Projects - GlaxoSmithKline

PERSPECTIVES

Page 31: John Dyson Head of Global Capital Projects - GlaxoSmithKline

Model what a facility may look like

For different Categories in the business

Page 32: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 33: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 34: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 35: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 36: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 37: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 38: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 39: John Dyson Head of Global Capital Projects - GlaxoSmithKline

STANDARDISATION & DELIVERY

Page 40: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 41: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 42: John Dyson Head of Global Capital Projects - GlaxoSmithKline
Page 43: John Dyson Head of Global Capital Projects - GlaxoSmithKline